Korea Heart Disease Fact Sheet 2020: Analysis of Nationwide Data

Lee, Hyeok-Hee; Cho, So Mi Jemma; Lee, Hokyou; Baek, Jeonghyun; Bae, Jang Ho; Chung, Wook‐Jin; Kim, Hyeon Chang

doi:10.4070/kcj.2021.0097

Cited by 81 publications

(74 citation statements)

References 18 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The cardiovascular disease mortality rate has been decreasing in Korea; nonetheless, heart disease, cerebrovascular disease and hypertensive disorders remain as the second, fourth and ninth common causes of death, respectively [ 4 ]. Moreover, due to the rapid aging of the population and improved prognosis from cardiovascular event, the absolute number of patients with cardiovascular disease continues to increase [ 5 ]. According to the National Health Insurance Service (NHIS) statistics in Korea, the estimated medical cost of treating hypertension was 3830 billion Korean Won, accounting for 4% of all medical expenses or 16% of medical expenses for chronic diseases [ 6 ].…”

Section: Introductionmentioning

confidence: 99%

Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2021 to provide an overview of the magnitude and management status of hypertension and their recent trends. Methods The Fact Sheets were based on the analyses of Korean adults aged 20 years or older of the 1998–2019 Korea National Health and Nutrition Examination Survey and the 2002–2019 National Health Insurance Big Data. Results Currently, the population average of systolic/diastolic blood pressure was 119/76 mmHg in Korean adults aged 20 years or older showing little change in the recent decade. It is estimated that 28% of the adult population aged 20 or older (33% of adults aged 30 or older) have hypertension. The estimated number of people with hypertension was 6.30 million for men and 5.77 million for women, and 1.96 million for men and 2.99 million for women among the population aged 65 or older. The number of people diagnosed with hypertension increased from 3.0 million in 2002 to 10.1 million in 2019. During the same period, the number of people using antihypertensive medication increased from 2.5 million to 9.5 million, and the number of people adherent to treatment increased from 0.6 million to 6.9 million. Among antihypertensive prescriptions, 40.6% of the patients received monotherapy, 43.4% received dual therapy, and 16.0% received triple or more therapy. The most commonly prescribed antihypertensive medication was angiotensin receptor blockers (ARB), followed by calcium channel blockers (CCB) and diuretics. In young women, angiotensin-converting enzyme inhibitors (ACEi), ARB and CCB are less frequently prescribed than in men, but 59.5% of hypertensive women aged 20–39 are prescribed ACEi or ARBs. Hypertensive disorders during pregnancy have been increasing over the past 10 years. In 2019, 5.4% of women who gave birth were diagnosed with chronic hypertension and 3.1% with pregnancy-induced hypertension. Conclusions To achieve further improvement in management of hypertension, we need to encourage awareness and treatment in young adults. It is required to develop tailored prevention and management strategies that are appropriate for and inclusive of various demographics.

show abstract

Section: Introductionmentioning

confidence: 99%

Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…Among CVDs, ischemic heart disease (IHD) affects as many as 126 million people, accounting for an estimate of 1.72% of the global population [ 1 , 2 , 3 ]. IHD is also the leading cause of death in Korea and has increased gradually over the last decade with rapid population aging [ 4 ]. Thus, the emphasis should be placed on screening high-risk individuals and taking appropriate preventative measures to control the occurrence of IHD events.…”

Section: Introductionmentioning

confidence: 99%

“…Post hoc analysis with the Bonferroni method: a, Q1 versus Q2; b, Q1 versus Q3; c, Q1 versus Q4; d, Q2 versus Q3; e, Q2 versus Q4; and f, Q3 versus Q4 3. Alcohol intake ≥ 140 g/week 4. Moderate-intensity physical exercise ≥ three times/week.…”

mentioning

confidence: 99%

Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans

et al. 2021

View full text Add to dashboard Cite

The atherogenic index of plasma (AIP), composed of triglycerides and high-density lipoprotein cholesterol, is a novel critical marker for assessing the risk of atherogenicity and cardiometabolic health. We aimed to prospectively study the association between AIP and incident ischemic heart disease (IHD) risk in a large cohort of non-diabetic Korean adults. Data were assessed from 17,944 participants without diabetes from the Health Risk Assessment Study (HERAS) and Korea Health Insurance Review and Assessment (HIRA) data. The participants were divided into four groups according to AIP quartiles, calculated as log (triglyceride/high-density lipoprotein cholesterol). We prospectively assessed hazard ratios (HRs) with 95% confidence intervals (CIs) for IHD using multivariate Cox proportional-hazard regression models over a 50-month period that followed the baseline survey. During the follow-up period, 332 participants (1.9%) developed IHD. HRs of IHD for AIP quartiles 2–4 were 1.58 (95% CI, 1.03–2.43), 1.82 (95% CI, 1.20–2.78), and 2.11 (95% CI, 1.37–3.24) after adjusting for age, sex, body mass index, smoking status, alcohol intake, physical activity, mean arterial blood pressure, fasting plasma glucose, high-sensitivity C-reactive protein level, and hypertension medication. Higher AIP levels may precede and predict the development of IHD in non-diabetic Korean adults.

show abstract

“…The above-mentioned temporal trends in CVD morbidity and mortality have also been observed in South Korea (hereafter Korea) 3) 4) and Japan. 5) Since Korea is the fastest aging country in the world 6) and Japan is the most aged one, 7) it is not unexpected that CVDs will remain the chief contributor to morbidity and mortality in both countries.…”

Section: Introductionmentioning

confidence: 72%

Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan

et al. 2021

Self Cite

View full text Add to dashboard Cite

Author's summary Hypertension, diabetes, dyslipidemia, cigarette smoking, physical inactivity, obesity, and poor-quality diet are major modifiable risk factors for cardiovascular disease (CVD) in Korean and Japanese populations. In both Korea and Japan, physical inactivity exhibits the highest prevalence among the risk factors, followed by hypertension in Japan or obesity in Korea. Implementation of the primordial prevention strategies focused on the above-mentioned risk factors should be the priority of the health policymakers to tackle the growing burden of CVD in both countries.

show abstract

Korea Heart Disease Fact Sheet 2020: Analysis of Nationwide Data

Cited by 81 publications

References 18 publications

Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women

Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women

Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans

Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan

Contact Info

Product

Resources

About